Back to Search Start Over

127P Phase I study of fianlimab: A human lymphocyte activation gene-3 (LAG-3) monoclonal antibody, in combination with cemiplimab in advanced NSCLC

Authors :
B.C. Cho
G. Dy
T.M. Kim
D. Sarker
O. Hamid
S. Williamson
K. Sang-We
H. Hatim
S. Chen
J. Mani
V. Jankovic
A.J. Paccaly
S. Masinde
I. Lowy
L. Brennan
G. Gullo
Source :
Immuno-Oncology and Technology. 16:100239
Publication Year :
2022
Publisher :
Elsevier BV, 2022.

Subjects

Subjects :
Oncology
Immunology and Allergy

Details

ISSN :
25900188
Volume :
16
Database :
OpenAIRE
Journal :
Immuno-Oncology and Technology
Accession number :
edsair.doi...........0509b3c34fdc5a7137b15b9c2a272a4d

Tools

Authors Abstract Subjects Details